Neoadjuvant immunochemotherapy—a promising strategy for primary pulmonary lymphoepithelioma-like carcinoma

Neoadjuvant immunochemotherapy—a promising strategy for primary pulmonary lymphoepithelioma-like carcinoma

Abstract Objective Neoadjuvant immunochemotherapy has been a promising choice for patients with locally advanced non-small cell cancer (NSCLC). However, whether neoadjuvant immunochemotherapy impacted the subsequent surgical or pathological outcomes of patients with pulmonary lymphoepithelioma-like...

Full description

Bibliographic Details
Main Authors: Jiawei Chen, Lei Fan, Hongsheng Deng, Liang Li, Shuben Li
Format: Article
Language:English
Published: BMC 2024-12-01
Series:World Journal of Surgical Oncology
Subjects:
Neoadjuvant immunochemotherapy
Pulmonary lymphoepithelioma-like carcinoma
Surgery
Online Access:https://doi.org/10.1186/s12957-024-03617-w

Internet

https://doi.org/10.1186/s12957-024-03617-w

Similar Items